Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei I Molosh

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Progress in Brain Research|November 19, 2018
Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptomsAndrei I Molosh, Anantha Shekhar
Brain Research|September 12, 2018
Role of medial hypothalamic orexin system in panic, phobia and hypertensionAline R Abreu, Andrei I Molosh, Philip L Johnson, et al.
Nature|July 12, 2013
Generation of inner ear sensory epithelia from pluripotent stem cells in 3D cultureKarl R Koehler, Andrew M Mikosz, Andrei I Molosh, et al.
Neuroscience Letters|May 18, 2010
Increase in plasma ACTH induced by urethane is not a consequence of hyperosmolalityDmitry V Zaretsky, Andrei I Molosh, Maria V Zaretskaia, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2013
NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neuronsAndrei I Molosh, Tammy J Sajdyk, William A Truitt, et al.
Progress in Brain Research|November 19, 2018
From bedside to bench and back: Translating ASD modelsHayley P Drozd, Sotirios F Karathanasis, Andrei I Molosh, et al.
Neuroscience|March 30, 2022
CNO Administration Increases Dopamine and Glutamate in the Medial Prefrontal Cortex of Wistar Rats: Further Concerns for the Validity of the CNO-activated DREADD ProcedureZachary A Rodd, Eric A Engleman, William A Truitt, et al.
Peptides|September 4, 2020
Atrial natriuretic peptide (ANP): A novel mechanism for reducing ethanol consumption and seeking behaviors in female alcohol preferring (P) ratsSheketha R Hauser, Robert A Waeiss, Andrei I Molosh, et al.
Journal of Psychopharmacology (Oxford, England)|March 11, 2020
Using loss- and gain-of-function approaches to target amygdala-projecting serotonergic neurons in the dorsal raphe nucleus that enhance anxiety-related and conditioned fear behaviorsCristian S Bernabe, Izabela F Caliman, William A Truitt, et al.
Translational Psychiatry|January 24, 2019
Assessment of fear and anxiety associated behaviors, physiology and neural circuits in rats with reduced serotonin transporter (SERT) levelsPhilip L Johnson, Andrei I Molosh, Lauren M Federici, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Progress in Brain Research|November 19, 2018
Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptomsAndrei I Molosh, Anantha Shekhar
Brain Research|September 12, 2018
Role of medial hypothalamic orexin system in panic, phobia and hypertensionAline R Abreu, Andrei I Molosh, Philip L Johnson, et al.
Nature|July 12, 2013
Generation of inner ear sensory epithelia from pluripotent stem cells in 3D cultureKarl R Koehler, Andrew M Mikosz, Andrei I Molosh, et al.
Neuroscience Letters|May 18, 2010
Increase in plasma ACTH induced by urethane is not a consequence of hyperosmolalityDmitry V Zaretsky, Andrei I Molosh, Maria V Zaretskaia, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2013
NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neuronsAndrei I Molosh, Tammy J Sajdyk, William A Truitt, et al.
Progress in Brain Research|November 19, 2018
From bedside to bench and back: Translating ASD modelsHayley P Drozd, Sotirios F Karathanasis, Andrei I Molosh, et al.
Neuroscience|March 30, 2022
CNO Administration Increases Dopamine and Glutamate in the Medial Prefrontal Cortex of Wistar Rats: Further Concerns for the Validity of the CNO-activated DREADD ProcedureZachary A Rodd, Eric A Engleman, William A Truitt, et al.
Peptides|September 4, 2020
Atrial natriuretic peptide (ANP): A novel mechanism for reducing ethanol consumption and seeking behaviors in female alcohol preferring (P) ratsSheketha R Hauser, Robert A Waeiss, Andrei I Molosh, et al.
Journal of Psychopharmacology (Oxford, England)|March 11, 2020
Using loss- and gain-of-function approaches to target amygdala-projecting serotonergic neurons in the dorsal raphe nucleus that enhance anxiety-related and conditioned fear behaviorsCristian S Bernabe, Izabela F Caliman, William A Truitt, et al.
Translational Psychiatry|January 24, 2019
Assessment of fear and anxiety associated behaviors, physiology and neural circuits in rats with reduced serotonin transporter (SERT) levelsPhilip L Johnson, Andrei I Molosh, Lauren M Federici, et al.
Pageof 2